Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALXN

Alexion

$129.73

0.83 (0.64%)

, AMGN

Amgen

$186.84

-0.13 (-0.07%)

08:01
02/21/19
02/21
08:01
02/21/19
08:01
Conference/Events
The ASBMT and CIBMTR to hold a meeting »

The Center for…

ALXN

Alexion

$129.73

0.83 (0.64%)

AMGN

Amgen

$186.84

-0.13 (-0.07%)

ATNM

Actinium Pharmaceuticals

$0.66

0.0961 (17.16%)

AXN

Aoxing Pharmaceutical

$0.00

(0.00%)

BLUE

Bluebird Bio

$133.31

-2.56 (-1.88%)

CELG

Celgene

$90.39

-0.32 (-0.35%)

ORTX

Orchard Therapeutics

$16.00

-0.25 (-1.54%)

OMER

Omeros

$14.67

0.79 (5.69%)

NVS

Novartis

$90.77

0.82 (0.91%)

MRK

Merck

$79.44

0.18 (0.23%)

STML

Stemline

$11.71

0.16 (1.39%)

SPPI

Spectrum

$11.61

-0.1 (-0.85%)

JAZZ

Jazz Pharmaceuticals

$126.72

-0.28 (-0.22%)

INCY

Incyte

$83.74

-0.33 (-0.39%)

SNY

Sanofi

$42.07

-0.14 (-0.33%)

SHPG

Shire

$0.00

(0.00%)

HSGX

Histogenics

$0.13

0.0046 (3.56%)

GLYC

GlycoMimetics

$11.85

0.24 (2.07%)

SGEN

Seattle Genetics

$69.78

-0.22 (-0.31%)

PFE

Pfizer

$42.21

-0.37 (-0.87%)

GILD

Gilead

$66.98

0.22 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 07

    Mar

  • 11

    Mar

  • 18

    Mar

  • 19

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 24

    May

  • 28

    May

  • 17

    Jun

Yesterday
CVS

CVS Health

$63.82

-6.1 (-8.72%)

, LUV

Southwest

$54.63

-3.03 (-5.25%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CVS

CVS Health

$63.82

-6.1 (-8.72%)

LUV

Southwest

$54.63

-3.03 (-5.25%)

SCHW

Charles Schwab

$45.95

-1.11 (-2.36%)

ETFC

E-Trade

$48.05

-0.61 (-1.25%)

PANW

Palo Alto Networks

$228.77

-1.42 (-0.62%)

TEVA

Teva

$17.40

-0.61 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 04

    Mar

  • 05

    Mar

AMGN

Amgen

$186.97

-1.34 (-0.71%)

, ABBV

AbbVie

$80.50

-0.35 (-0.43%)

07:50
02/20/19
02/20
07:50
02/20/19
07:50
Recommendations
Amgen, AbbVie, Novartis analyst commentary at Morgan Stanley »

Amgen could fall over 10%…

AMGN

Amgen

$186.97

-1.34 (-0.71%)

ABBV

AbbVie

$80.50

-0.35 (-0.43%)

NVS

Novartis

$89.95

0.06 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 18

    Mar

  • 19

    Mar

  • 18

    May

TEVA

Teva

$18.01

0.02 (0.11%)

04:48
02/20/19
02/20
04:48
02/20/19
04:48
Downgrade
Teva rating change at Mizuho »

Teva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Tuesday
TEVA

Teva

$18.01

0.02 (0.11%)

, AGN

Allergan

$137.94

-1.13 (-0.81%)

18:26
02/19/19
02/19
18:26
02/19/19
18:26
Hot Stocks
Teva finalizes settlement with FTC to resolve all outstanding litigation »

Teva Pharmaceutical…

TEVA

Teva

$18.01

0.02 (0.11%)

AGN

Allergan

$137.94

-1.13 (-0.81%)

ABBV

AbbVie

$80.50

-0.35 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 18

    May

  • 28

    May

TEVA

Teva

$18.06

0.07 (0.39%)

16:01
02/19/19
02/19
16:01
02/19/19
16:01
Hot Stocks
Teva's Everolimus granted tentative approval by FDA »

The FDA granted tentative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Saturday
AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

Friday
AMGN

Amgen

$186.71

-0.74 (-0.39%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/15/19
02/15
04:55
02/15/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$186.71

-0.74 (-0.39%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$39.99

3.42 (9.35%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$50.83

-0.14 (-0.27%)

CALA

Calithera Biosciences

$5.21

-0.07 (-1.33%)

CLVS

Clovis

$25.44

0.37 (1.48%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.31

0.25 (1.13%)

IMMU

Immunomedics

$14.00

-0.3 (-2.10%)

INO

Inovio

$3.69

-0.995 (-21.26%)

MRK

Merck

$78.94

-0.08 (-0.10%)

MYOV

Myovant Sciences

$21.38

-0.11 (-0.51%)

MYGN

Myriad Genetics

$30.88

0.72 (2.39%)

NH

NantHealth

$0.60

0.0202 (3.48%)

NVS

Novartis

$89.03

0.195 (0.22%)

PFE

Pfizer

$41.96

0.27 (0.65%)

PGNX

Progenics

$4.74

0.14 (3.04%)

SGEN

Seattle Genetics

$68.56

0.2 (0.29%)

SNY

Sanofi

$41.57

-0.06 (-0.14%)

TYME

Tyme Technologies

$3.13

-0.05 (-1.57%)

AVEO

Aveo Pharmaceuticals

$0.61

0.021 (3.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

Over a week ago
TEVA

Teva

$17.39

-0.24 (-1.36%)

12:26
02/14/19
02/14
12:26
02/14/19
12:26
Recommendations
Teva analyst commentary at Wells Fargo »

Teva price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$76.02

-0.24 (-0.31%)

, SYF

Synchrony

$30.81

0.03 (0.10%)

10:12
02/14/19
02/14
10:12
02/14/19
10:12
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

XOM

Exxon Mobil

$76.02

-0.24 (-0.31%)

SYF

Synchrony

$30.81

0.03 (0.10%)

TEVA

Teva

$17.71

0.08 (0.45%)

ELVT

Elevate Credit

$4.51

0.04 (0.89%)

NTAP

NetApp

$62.93

-4.29 (-6.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 25

    Feb

  • 03

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.